Insider trading · Q3 2026 · CIK 1787306

Arcutis Biotherapeutics, Inc. (ARQT) insider trading.

Name: Arcutis Biotherapeutics, Inc. insider transactions, Q3 2026
Creator: U.S. Securities and Exchange Commission

In Q3 2026, insiders at Arcutis Biotherapeutics, Inc. reported 29 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 14 sales worth $2.3M.

Transactions: 29
Purchases (P): 0
Sales (S): 14
Net shares, P minus S: -90,382
Insiders: 6
Last filed: 2026-09-18

Insiders

Insider	Relationship	Transactions	Sales
Welgus Howard G.	Director	12	3
Curran Terrie	Director	6	3
Burnett Patrick	Officer · See Remarks	6	4
Matsuda Masaru	Officer · See Remarks	3	3
Watanabe Todd	Director, Officer · See Remarks	1	1
Peetz Christopher	Director	1	0

Transactions

29 non-derivative rows, newest transaction first. Shares and prices as filed.
Date	Insider	Code	Shares	Price	Owned after	Filing
2026-09-16	Matsuda Masaru	S (D)	3,674	$25	112,508	Form 4
2026-09-15	Welgus Howard G.	M (A)	822	$6.52	37,297	Form 4
2026-09-15	Welgus Howard G.	S (D)	4,730	$24.18	35,841	Form 4
2026-09-15	Welgus Howard G.	M (A)	2,255	$8.63	40,571	Form 4
2026-09-15	Welgus Howard G.	M (A)	1,019	$7.51	38,316	Form 4
2026-09-08	Matsuda Masaru	S (D)	9,989	$25.03	116,182	Form 4
2026-08-27	Curran Terrie	M (A)	27,052	$8.63	50,578	Form 4
2026-08-27	Curran Terrie	S (D)	11,148	$25.03	23,526	Form 4
2026-08-27	Curran Terrie	M (A)	11,148	$7.51	34,674	Form 4
2026-08-27	Curran Terrie	S (D)	27,052	$25.03	23,526	Form 4
2026-08-20	Curran Terrie	M (A)	1,072	$7.51	24,598	Form 4
2026-08-20	Curran Terrie	S (D)	1,072	$26.04	23,526	Form 4
2026-08-19	Burnett Patrick	S (D)	1,697	$27	117,592	Form 4
2026-08-17	Welgus Howard G.	M (A)	2,255	$8.63	41,205	Form 4
2026-08-17	Welgus Howard G.	M (A)	1,019	$7.51	38,950	Form 4
2026-08-17	Welgus Howard G.	M (A)	822	$6.52	37,931	Form 4
2026-08-17	Welgus Howard G.	S (D)	4,730	$26.18	36,475	Form 4
2026-08-12	Burnett Patrick	S (D)	6,700	$26.08	119,289	Form 4
2026-08-12	Burnett Patrick	M (A)	6,700	$3.64	125,989	Form 4
2026-08-11	Burnett Patrick	S (D)	8,300	$26.52	119,289	Form 4
2026-08-11	Burnett Patrick	M (A)	8,300	$3.64	127,589	Form 4
2026-08-03	Watanabe Todd	S (D)	4,375	$26.12	717,203	Form 4
2026-08-03	Matsuda Masaru	S (D)	1,230	$26.12	126,171	Form 4
2026-08-03	Burnett Patrick	S (D)	955	$26.12	119,289	Form 4
2026-07-15	Welgus Howard G.	M (A)	2,255	$8.63	41,839	Form 4
2026-07-15	Welgus Howard G.	S (D)	4,730	$26.91	37,109	Form 4
2026-07-15	Welgus Howard G.	M (A)	1,019	$7.51	39,584	Form 4
2026-07-15	Welgus Howard G.	M (A)	822	$6.52	38,565	Form 4
2026-07-15	Peetz Christopher	A (A)	4,315	$0	4,315	Form 4

Transaction codes in this quarter

S: 14 M: 14 A: 1

Get ARQT insider transactions through the API

Request with your API key

curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1787306&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · ARQT company page · Arcutis Biotherapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Arcutis Biotherapeutics, Inc. (ARQT)?

In Q3 2026, insiders at Arcutis Biotherapeutics, Inc. reported 29 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 14 sales worth $2.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Arcutis Biotherapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/arqt.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.